
Modern drug design software for medicinal chemists
1 signal in the last 90 days.
The order this company entered each market — oldest to newest
DeepMirror Brings OpenClaw to Unitree Robots
Sign up to see the full signal feed
How DeepMirror's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
DeepMirrorYou | 1 | 1 | -100% | 1 | 11 |
ML Engineer
View postingLondon, England, United Kingdom · 2mo ago
UI/UX Designer (Part-Time Maternity Cover)
View postingLondon, England, United Kingdom · 4mo ago
Research Engineer (Molecular AI)
View postingLondon, England, United Kingdom · 4mo ago
No active campaigns
Sign up to track this company and get alerted the moment something changes.
DeepMirror introduces OpenClaw runtime for physical AI, enabling AI agents to transition from digital tasks to real-world execution on Unitree robots.
DeepMirror, a Greek-origin AI startup, raised $2.4 million in seed funding to revolutionize drug discovery, aiming to reduce costs and time in pharmaceutical development using AI.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about DeepMirror's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.